“pfizer” Archives

in
Entry Author Date Location
Sarepta’s Data Are First in Rush for Duchenne Gene Therapy 06/19/18 Boston
As Sarepta Preps Data, FDA Lifts Hold on Solid’s Duchenne Gene Therapy 06/18/18 Boston
Bio Roundup: Brii Does China, Hemophilia Updates, Right to Try & More 05/25/18 National
Brii Biosciences Debuts with a China Pharma Strategy Backed by $260M 05/24/18 Raleigh Durham
Bio Roundup: ASCO Abstracts, Migraine Drug Prices & “Blueprint” Fallout 05/18/18 National
Verdine Picks Backers For FogPharma’s $66M Round, Keeping Firm Control 05/16/18 Boston
Rapamycin Holdings Plans Tests of Old Immune Drug in Prostate Cancer 05/09/18 Texas
FDA Panel Splits on Lilly Arthritis Drug, Backs Lower of Two Doses 04/23/18 Indiana
With Alzheimer’s Failure, vTv Fares No Better Than Old Partner Pfizer 04/09/18 Raleigh Durham
Conatus Pharma’s Liver Disease Drug Flunks First Phase 2 Test 04/05/18 San Diego
Ex-Kite Execs Resurface with $300M and Control of Pfizer CAR-T Cells 04/03/18 San Francisco
Bio Roundup: Biotech IPOs, Migraine Progress, Takeda Woos Shire & More 03/30/18 National
Bio Roundup: DIY Biohacking, PCSK9 Data, Solid Setback & More 03/16/18 National
Ionis Sends Nerve Drug to Spinout Akcea as Battle with Alnylam Looms 03/15/18 Boston
Biogen to Acquire Phase 2-Ready Schizophenia Drug from Pfizer 03/12/18 Boston
After Paper Shakes Sector, Gene Therapy Leader Jim Wilson Talks Safety 01/30/18 National
Solid Discloses Duchenne Problems in IPO & Raises Rival’s Hackles 01/25/18 Boston
Have $100M, Looking For Ideas: NYCEDC Begins Search For a NY Bio Campus 01/24/18 New York
Pandion Raises $58M to Bring Cancer-Fighting Tactics to Immune Disorders 01/18/18 Boston
Bio Roundup: #JPM18, Axovant’s Fall, CRISPR Caveat, Impact M&A & More 01/12/18 National
Stop Being an “Initiative”: Highlights From NY Biotech—The Future Is Now 12/20/17 New York
Last Chance to Have Your Voice Heard on NY Biotech’s Course in 2018 12/07/17 New York
First Video Game Therapy Heads to FDA as Akili Touts ADHD Study Win 12/04/17 Boston
15 For ’18: Key Clinical Data to Watch For Next Year (Part 1) 12/04/17 National
Bio Roundup: Migraine Data, Cancer Drug Combos, Azar Hearing & More 12/01/17 National
Medicines Co. Sells Infectious Disease Drugs, Focusing on PCSK9 11/29/17 New York
Chemo Tops Pfizer, Merck KGaA Drug in Big Stomach Cancer Test 11/28/17 New York
What Steps Should NY Biotech Take in 2018? Share Your View on Dec. 11 11/20/17 New York
Healthcare + A.I. in Boston: The Photos 11/16/17 Boston
FDA Lifts Hold on Cellectis’s “Off the Shelf” CAR-T, With Caveats 11/07/17 New York
Page 1 of 27 next page »